Suppr超能文献

血管内动脉瘤修复后的晚期事件和中期结果。

Late events and mid-term results after endovascular aneurysm repair.

机构信息

Department of Vascular Surgery, Aichi Medical University Hospital, Nagakute, Aichi, 480-1195, Japan,

出版信息

Surg Today. 2014 Jan;44(1):50-4. doi: 10.1007/s00595-012-0472-6. Epub 2013 Jan 3.

Abstract

PURPOSE

To evaluate the late events and mid-term results after endovascular aneurysm repair (EVAR).

METHODS

Between December 2006 and May 2012, 175 abdominal aortic aneurysms were treated by EVAR. Aneurysm-related events were analyzed.

RESULTS

The complications that occurred during the EVAR procedure were renal artery occlusion in two patients, access artery injury in two, delivery failure in one, retrograde aortic dissection in one, and death from hepatic failure in one patient. Five adverse endoleaks (four type I, one type III) remained at discharge, and the technical success rate was 97 %. On follow-up, limb occlusion had occurred in five patients. Unilateral renal atrophy was found in three patients, but none of the patients required new hemodialysis. Sac enlargement (≥5 mm) developed in ten patients. Their culprit endoleaks were type Ia in one, II in eight, and V in one patient. Transarterial embolization was performed for three out of the eight type II endoleaks. The rate of freedom from secondary re-intervention was 93 % at 3 and 5 years, respectively. The survival and freedom from aneurysm-related events rates were 74 % at 3 years and 47 % at 5 years.

CONCLUSIONS

The mid-term results of EVAR were excellent with a low rate of aneurysm-related deaths, although there were relatively high aneurysm-related event rates. Sac re-enlargement from type II endoleaks was the most common major issue at the mid-term follow-up.

摘要

目的

评估血管内动脉瘤修复术(EVAR)后的晚期事件和中期结果。

方法

2006 年 12 月至 2012 年 5 月,对 175 例腹主动脉瘤进行了 EVAR 治疗。分析了与动脉瘤相关的事件。

结果

EVAR 术中发生的并发症有 2 例肾动脉闭塞,2 例入路动脉损伤,1 例输送失败,1 例逆行主动脉夹层,1 例肝衰竭死亡。出院时仍有 5 例不良内漏(4 型 I,1 型 III),技术成功率为 97%。随访时,5 例患者出现肢体闭塞。3 例患者发现单侧肾萎缩,但均无需新行血液透析。10 例患者出现囊腔扩大(≥5mm)。其中 1 例为 I 型,8 例为 II 型,1 例为 V 型。8 例 II 型内漏中有 3 例行经动脉栓塞治疗。二次介入治疗的无复发生存率分别为 3 年和 5 年时的 93%。3 年和 5 年时的生存率和免于动脉瘤相关事件的生存率分别为 74%和 47%。

结论

EVAR 的中期结果良好,动脉瘤相关死亡率较低,但动脉瘤相关事件发生率相对较高。II 型内漏导致的囊腔再扩大是中期随访中最常见的主要问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验